The A/C Diagnostics unit of AntiCancer Inc, has received FDA clearance to market its A/C Enzymatic Homocysteine Assay. The fully automated assay will facilitate widespread testing for homocysteine, a risk factor for cardiovascular and other diseases. The throughput of this assay is 360 tests per hour.
A/C Diagnostics LLC
www.CLPmag.com
